Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Name: Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression
SKU: 24335
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 51 No. 3 Articles 2021 Tags: Aalim Weljie, Anup Sharma, Arjun Sengupta, depression, hiv, insomnia, Jennifer R. Goldschmied, Knashawn H. Morales, Lynne Taylor, Matthew S. Kayser, metabolomics, michael-e-thase, zaleplon

Description

Description

Original Research

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

By Jennifer R. Goldschmied, Arjun Sengupta, Anup Sharma, Lynne Taylor, Knashawn H. Morales, Michael E. Thase, Aalim Weljie, and Matthew S. Kayser

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Description

Original Research

Gender-Specific Differences in Depression and Treatment Response

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder

Title

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Description

Original Research

Related products

Gender-Specific Differences in Depression and Treatment Response

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder

Title